Who is sponsoring NCT05352555?

NCT05352555 is sponsored by Stratejik Yenilikci Girisimler Ltd..

What drugs are being tested in NCT05352555?

Interventions in NCT05352555: Automated vertigo repositioning chair, Canalith Reposition Maneuver.

What condition does NCT05352555 study?

NCT05352555 studies Benign Paroxysmal Positional Vertigo.

Is NCT05352555 still recruiting?

NCT05352555 is currently completed. Last updated 29 April 2022.

Last reviewed 2022-04-29 · How we verify

NCT05352555

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Automated Robotic Maneuvering System (RMS) vs Manual Reposition Maneuver in Treatment of Benign Paroxysmal Positional Vertigo (BPPV)

Completed Phase 1, PHASE2 Last updated 29 April 2022

What this trial tests

Phase 1, PHASE2 trial testing Automated vertigo repositioning chair in Benign Paroxysmal Positional Vertigo in 75 participants. Completed in 23 April 2022.

Timeline

15 February 2022

Primary endpoint
12 April 2022

23 April 2022

Quick facts

Lead sponsor	Stratejik Yenilikci Girisimler Ltd.
Phase	Phase 1, PHASE2
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	75
Start date	15 February 2022
Primary completion	12 April 2022
Estimated completion	23 April 2022
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Automated vertigo repositioning chair
Canalith Reposition Maneuver

Conditions studied

Benign Paroxysmal Positional Vertigo — all drugs for Benign Paroxysmal Positional Vertigo →

Sponsor

Stratejik Yenilikci Girisimler Ltd.

Who can join

Adults 18 to 80, any sex, with Benign Paroxysmal Positional Vertigo. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Comparison of treatment efficacy of an automated robotic maneuvering system (RMS) repositioning chair versus manual positioning maneuvers in Benign Paroxysmal Positional Vertigo.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Benign Paroxysmal Positional Vertigo

Currently open trials in the same condition.

NCT06738823 — Effect of Wii Fit Training in Comparison to Vestibular Rehabilitation Training on Balance in Patients With Benign Paroxy · NA · recruiting
NCT06725966 — Personalized Treatment of Refractory BPPV · NA · recruiting
NCT06001047 — Head Acupuncture Treat Residual Symptoms After Canalith Repositioning Procedure for BPPV · NA · recruiting
NCT06314581 — Effect of a Multifaceted Educational Intervention on the Implementation of Evidence-based Practices for Benign Paroxysma · active not recruiting
NCT05834452 — Treatment of Posterior Benign Paroxysmal Positional Vertigo With Mechanical Rotational Chair. · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05352555 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Stratejik Yenilikci Girisimler Ltd.
Last refreshed: 29 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05352555.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing